BI Asset Management Fondsmaeglerselskab’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-442
Closed -$56K 664
2024
Q2
$56K Sell
442
-2,406
-84% -$377K ﹤0.01% 618
2024
Q1
$524K Buy
2,848
+1,806
+173% +$344K 0.01% 517
2023
Q4
$187K Hold
1,042
﹤0.01% 656
2023
Q3
$166K Hold
1,042
﹤0.01% 634
2023
Q2
$147K Buy
1,042
+833
+399% +$134K ﹤0.01% 645
2023
Q1
$35K Buy
209
+114
+120% +$20.3K ﹤0.01% 713
2022
Q4
$16K Buy
+95
New +$17.2K ﹤0.01% 660
2019
Q4
Sell
-17,117
Closed -$1.31M 414
2019
Q3
$1.31M Buy
+17,117
New +$1.5M 0.06% 208

Other funds holding RGEN

BI Asset Management Fondsmaeglerselskab's RGEN Position: Q3 2024 in Review

BI Asset Management Fondsmaeglerselskab sold out of Repligen (RGEN) in Q3 2024, closing a stake of 442 shares — an estimated $56K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in RGEN in Q3 2019 and held it in 8 quarters. The position peaked at $1.31M in Q3 2019. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 442 Repligen shares in Q3 2024, an estimated $56K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Repligen in Q3 2019 and held it in 8 quarters.
  • BI Asset Management Fondsmaeglerselskab's Repligen position peaked at $1.31M in Q3 2019.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q3 2024, filed 13 Nov 2024.